Chikungunya infection: A potential re-emerging global threat.

Infectious diseases are indeed a lifelong threat to everyone irrespective of age, sex, lifestyle and socio-economic status. The infectious diseases have persisted among the prominent causes of death globally. Recently, re-emergence of Chikungunya viral infection harmed many in Asian and African countries. Chikungunya was considered as a major threat in developing and under-developed countries; the recent epidemiological outbreak of Chikungunya in La Reunion urges the global researchers to develop effective vaccine against this viral disease. In this review, Chikungunya, pathogenesis and epidemiology were briefly described.

[1]  M. Albert,et al.  Biology and pathogenesis of chikungunya virus , 2010, Nature Reviews Microbiology.

[2]  J. Chu,et al.  Replication of Alphaviruses: A Review on the Entry Process of Alphaviruses into Cells , 2011, Advances in virology.

[3]  D. Mavalankar,et al.  Increased Mortality Rate Associated with Chikungunya Epidemic, Ahmedabad, India , 2008, Emerging infectious diseases.

[4]  J. Smit,et al.  Early Events in Chikungunya Virus Infection—From Virus Cell Binding to Membrane Fusion , 2015, Viruses.

[5]  N. Wauquier,et al.  Unconventional Repertoire Profile Is Imprinted during Acute Chikungunya Infection for Natural Killer Cells Polarization toward Cytotoxicity , 2011, PLoS pathogens.

[6]  Y. Kawaoka,et al.  Emerging viral diseases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Ramasamy,et al.  Biological Differences between Brackish and Fresh Water-Derived Aedes aegypti from Two Locations in the Jaffna Peninsula of Sri Lanka and the Implications for Arboviral Disease Transmission , 2014, PloS one.

[8]  M. Landini,et al.  Chikungunya: an emerging and spreading arthropod-borne viral disease. , 2009, Journal of infection in developing countries.

[9]  E. Gould,et al.  Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy , 2013, Antiviral Research.

[10]  A. P. Adams,et al.  Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. , 2014, The Journal of infectious diseases.

[11]  M. Szczur,et al.  Surveillance of Arthropod Vector-Borne Infectious Diseases Using Remote Sensing Techniques: A Review , 2007, PLoS pathogens.

[12]  D. Grace,et al.  Zoonotic Emerging Infectious Disease in Selected Countries in Southeast Asia: Insights from Ecohealth , 2011, EcoHealth.

[13]  J. H. Strauss,et al.  Sindbis virus RNA polymerase is degraded by the N-end rule pathway. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. H. Strauss,et al.  Mapping the structure and function of the E1 and E2 glycoproteins in alphaviruses. , 2006, Structure.

[15]  M. Ponnaiah,et al.  Impact of Chikungunya on Health Related Quality of Life Chennai, South India , 2012, PloS one.

[16]  E. Wang,et al.  Chimeric Chikungunya Viruses Are Nonpathogenic in Highly Sensitive Mouse Models but Efficiently Induce a Protective Immune Response , 2011, Journal of Virology.

[17]  David L. Smith,et al.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus , 2015, eLife.

[18]  L. Rychlewski,et al.  Alphaherpesvirinae and Gammaherpesvirinae glycoprotein L and CMV UL130 originate from chemokines , 2013, Virology Journal.

[19]  I. Yoon,et al.  Chikungunya Fever Outbreak, Bhutan, 2012 , 2013, Emerging infectious diseases.

[20]  Kara E. Rudolph,et al.  Incubation periods of mosquito-borne viral infections: a systematic review. , 2014, The American journal of tropical medicine and hygiene.

[21]  I. Messaoudi,et al.  Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model) , 2015, Pathogens.

[22]  S. Boulant,et al.  Dynamics of Virus-Receptor Interactions in Virus Binding, Signaling, and Endocytosis , 2015, Viruses.

[23]  N. Sardesai,et al.  A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates , 2011, PLoS neglected tropical diseases.

[24]  A. Wilder-Smith,et al.  Epidemiology of dengue: past, present and future prospects , 2013, Clinical epidemiology.

[25]  X. de Lamballerie,et al.  Chikungunya Infection: An Emerging Rheumatism Among Travelers Returned From Indian Ocean Islands. Report of 47 Cases , 2007, Medicine.

[26]  J. Chu,et al.  Comparative analysis of the genome sequences and replication profiles of chikungunya virus isolates within the East, Central and South African (ECSA) lineage , 2013, Virology Journal.

[27]  R. Kuhn,et al.  Identification of a region in the Sindbis virus nucleocapsid protein that is involved in specificity of RNA encapsidation , 1996, Journal of virology.

[28]  S. Mukhopadhyay,et al.  The Alphavirus E3 Glycoprotein Functions in a Clade-Specific Manner , 2012, Journal of Virology.

[29]  J. Hobson-Peters,et al.  The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition , 2015, Viruses.

[30]  L. Ng,et al.  Chikungunya: a bending reality. , 2009, Microbes and infection.

[31]  Scott C Weaver,et al.  Chikungunya virus and prospects for a vaccine , 2012, Expert review of vaccines.

[32]  P. Roques,et al.  Chikungunya Disease: Infection-Associated Markers from the Acute to the Chronic Phase of Arbovirus-Induced Arthralgia , 2012, PLoS neglected tropical diseases.

[33]  M. Strobel,et al.  Chikungunya, an epidemic arbovirosis. , 2007, The Lancet. Infectious diseases.

[34]  S. Weaver,et al.  Present and future arboviral threats. , 2010, Antiviral research.

[35]  Hung-Jen Liu,et al.  Molecular Signaling and Cellular Pathways for Virus Entry , 2013 .

[36]  P. Parola,et al.  Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. , 2008, The Medical clinics of North America.

[37]  C. Lahariya,et al.  Emergence of chikungunya virus in Indian subcontinent after 32 years: A review. , 2006, Journal of vector borne diseases.

[38]  Santiago F. Elena,et al.  Adaptive Value of High Mutation Rates of RNA Viruses: Separating Causes from Consequences , 2005, Journal of Virology.

[39]  R. Ross A laboratory technique for studying the insect transmission of animal viruses, employing a bat-wing membrane, demonstrated with two African viruses , 1956, Journal of Hygiene.

[40]  R. Kuhn,et al.  A structural and functional perspective of alphavirus replication and assembly. , 2009, Future microbiology.

[41]  S. Chattopadhyay,et al.  A Novel 2006 Indian Outbreak Strain of Chikungunya Virus Exhibits Different Pattern of Infection as Compared to Prototype Strain , 2014, PloS one.

[42]  S. Higgs,et al.  Replication cycle of chikungunya: a re-emerging arbovirus. , 2009, Virology.

[43]  A. Flahault,et al.  The Chikungunya Epidemic on La Réunion Island in 2005–2006: A Cost-of-Illness Study , 2011, PLoS neglected tropical diseases.

[44]  M E Woolhouse,et al.  Risk factors for human disease emergence. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[45]  S. Higgs,et al.  Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction , 2011, Virology Journal.

[46]  R. Kincaid,et al.  Arthropod Vectors and Disease Transmission: Translational Aspects , 2015, PLoS neglected tropical diseases.

[47]  James M. Wagner,et al.  Enhanced Production of Chikungunya Virus-Like Particles Using a High-pH Adapted Spodoptera frugiperda Insect Cell Line , 2014, PloS one.

[48]  A. Suhrbier,et al.  A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. , 2011, Vaccine.

[49]  H. Guzmán,et al.  Genome-Scale Phylogeny of the Alphavirus Genus Suggests a Marine Origin , 2011, Journal of Virology.

[50]  J. Vlak,et al.  Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells , 2011, Virology Journal.

[51]  S. Cherian,et al.  Antiviral Perspectives for Chikungunya Virus , 2014, BioMed research international.

[52]  R. Kuhn,et al.  Molecular links between the E2 envelope glycoprotein and nucleocapsid core in Sindbis virus. , 2011, Journal of molecular biology.